Regulatory mechanisms of tyrosinase activity in melanocyte. I. by Seiji, M. et al.
YALE JOURNAL OF BIOLOGY AND MEDICINE 46, 508-515 (1973)
Regulatory Mechanisms of Tyrosinase Activity in Melanocyte. 1.
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Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan
The activity of tyrosinase (EC 1.10.3,1 o-diphenol:02 oxidoreductase) was
found to be in melanosomes, smooth-surface membranes, rough-surface mem-
branes, and ribosomes when they are isolated from Harding-Passey mouse mela-
noma. In vivo incorporation studies of 14C-dopa into these cell particles were car-
ried out in order to clarify the site of malanin formation in melanocytes. '4C-dopa
incorporation occurred only in melanosomes. If the site of the dopa incorporation
could be accepted as the site of melanin formation, it was concluded that melanin
was synthesized only in melanosomes (1). Although, in mammals, tyrosinase is
generally believed to occur only in the presence of melanin, and vice versa,
ried out in order to clarify the site of melanin formation in melanocytes. C'C-dopa
despite the presence of tyrosinase activity. It is considered, therefore, that the pres-
ence of tyrosinase activity is not necessarily correlated to the formation of melanin
in melanocyte. How does tyrosinase exist in smooth-surface membranes, rough-
surface membranes or ribosomes? Is it in a form of protyrosinase or is it inhibited
in some way?
The presence of naturally occurring inhibitors of tyrosinase has been reported
in the serum (2) and melanoma tissues (3-5). Satoh et al. (4) found the presence
of tyrosinase-inhibitory materials in the hamster melanomas, and they were shown
to be heat stable, dialyzable and did not exhibit sulfhydryl properties. Chian et
al. (5) have isolated the tyrosinase inhibitor from mouse melanomas, and it was
found to be heat stable, dialyzable and could be inactivated by ultraviolet irradia-
tion. The inhibitor isolated fully inhibited soluble tyrosinase but only partially in-
hibited melanosome tyrosinase.
In the present studies, the regulatory mechanisms of tyrosinase activity in the
melanocytes have been studied in vivo and in vitro. The tyrosinase-inhibitory mate-
rial was found to be present in the soluble fraction of melanoma tissue. The inhibi-
tory effect was examined in vitro on soluble tyrosinase and on tyrosinase associated
with smooth-surface membranes and melanosomes obtained from melanomas, and
also on melanogenesis in the melanocyte in vivo.
MATERIALS AND METHODS
1. Preparation of soluble tyrosinase. Harding-Passey mouse melanomas used in
the experiments reported here were serially transplanted into a strain of Swiss mice.
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The entire, actively growing tumors were excised when their diameter reached
1.0-1.5 cm, and were promptly homogenized in 5 vol ice-cold distilled water at
about 0°C. The homogenate was centrifuged at 700 g for 10 min and the super-
natant (1 mg protein/ml) was incubated with 200 jg of trypsin in %45 M phos-
phate buffer, pH 7.2 at 60C for 18 hr. After the digestion, the mixture was
centrifuged at 105,000 g for 60 min. The supernatant obtained was condensed and
subjected to gel filtration through a Sephadex G-100 column (2.5 X 100 cm),
equilibrated with a 0.01 M potassium phosphate buffer, pH 7.0; the elution
was conducted with the same buffer. Fractions of 5 ml were collected and
analyzed for protein and tyrosinase activity. Tyrosinase activity was recovered
in fractions 28-54. The tyrosinase-rich fractions of the Sephadex eluate (fractions
44-54) were combined, lyophilized, and kept in a deep freezer at -200C until
use.
2. Preparation of melanosomes and smooth-surface membranes. The entire,
actively growing melanoma was excised and homogenized in 0.25 M sucrose at
about 0°C. The cell fractionation method was essentially that of Seiji (1). The
nuclear fraction was prepared by centrifuging the homogenate for 10 min at 700
g. The resulting supernatant, when centrifuged at 11,000 g for 10 min, yielded
a sediment which was resuspended in 0.25 M sucrose and recentrifuged at 15,000
g for 10 min. The sediment was again suspended in 0.25 M sucrose and designated
as the large-granule fraction. The small-granule fraction was prepared by centri-
fuging the combined washings and supernatant from the large-granule fraction at
105,000 g for 60 min by an ultracentrifuge. Melanosomal fraction was prepared
from the large-granule fraction by density gradient centrifugation (6). The small-
granule fraction was further separated into smooth-surface membranes and rough-
surface membranes (7) with a slight modification.
3. Determination of tyrosinase activity. Tyrosinase activity was estimated
manometrically by measuring the oxygen consumption, using L-dopa as substrate
in M/10 phosphate buffer, pH 6.8, and was determined colorimetrically by the
initial rate of increase in optical density (expressed as AE/10 min), with 1 mg
of L-dopa in 5 ml of M/10 phosphate buffer, pH 6.8 (8). The optical density
was determined with Klett-Summerson photoelectric colorimeter (AE = scale
reading).
4. Determination of tyrosinase activity in the melanocyte. The melanotic cell
line C341, isolated from a culture cell line of mouse melanoma B-16 established
by Furuse et al. (9), was used in this series of experiments. Tyrosinase activity
in cultured melanocytes was assayed as described by Oikawa (10). The method
involved measurement of the amount of tritium released into the medium as water
from L-[3,5-3H2jtyrosine (11), since this was proportional to the amount of
melanin synthesized in the culture. 2 X 105 dispersed cells in 2 ml of culture me-
dium were incubated at 370C in a plastic dish with a surface area of 5cm2. The
medium consisted of 2 ml of Eagle's minimum essential medium supplemented
with 10% calf serum, 120 Mg of Kanamycin and L-[3,5-3H2]tyrosine (2 XCi/ml),
and was changed every 24 hr. Used media were analyzed for tritium released as
water from the labeled tyrosine. The rate of melanin synthesis is expressed as cpm
of radioactive hydrogen released as water from positions 3 and 5 of L-tyrosine.
The cell number was counted with a hemocytometer after trypsinization. Aliquots
of the filtrate were counted in a liquid scintillation counter (Packard model 3203
spectrometer).
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5. Chemicals. L-[3,5-3H2]tyrosine (51.7 Ci/mmole) came from The Radio-
chemical Center, Amersham, England. Culture medium and calf serum came from
Igaku-Seibutsugaku-Kenkyusho, Kawasaki, Japan.
6. Chemical analysis. The protein content was determined according to Lowry
etal. (12).
RESULTS
1. Preparation of tyrosinase inhibitor. The melanomas were excised and
promptly homogenized in 5 vol of ice-cold distilled water at about 0°C. The homo-
genate was centrifuged at 105,000 g for 60 min by a Hitachi ultracentrifuge. The
supernatant thus obtained was condensed. Ten milliliters of condensed supernatant
was subjected to gel filtration through a Sephadex G-100 Column (2.6 X 100 cm),
equilibrated with 0.01 M phosphate buffer, pH 7.0; the elution was conducted with
the same buffer. Fractions of 5 ml were collected, and the elution rate was about
15 ml/hr, at 40C. The absorbances at 280 nm were measured. Roughly four peaks
(I-IV) were obtained, as shown in Fig. 1, and the III and IV peaks showed the
inhibitory activities; the fractions between No. 88 and No. 120, which correspond
to the III peak and IV peak, were collected and again condensed. The condensed
material was chromatographed on a 1.5 X 30 cm column of diethylaminoethyl cel-
lulose-Sephadex A-25, equilibrated with 0.01 M potassium phosphate buffer, pH
7.0. Continuous gradient elution was then performed: A linear gradient from 0
to 0.2 M NaCl in 0.01 M potassium phosphate buffer, pH 7.0, was used. Fractions
of 5 ml were collected, and the absorbancies at 280 nm were measured. Figure
2 shows the elution pattern of the inhibitory materials. Four peaks: TyI,, TyI2,
TyI3, and TyI4 were obtained.
2. Inhibitory effects of Tyl subfractions on soluble-tyrosinase activity. The in-
hibitory activities of the four fractions thus obtained were examined manometri-
cally on the soluble-tyrosinase activity. The results obtained are listed in Table
1. The inhibitory activities of Fractions III and IV were reasonably high, but those
of Fractions I and II were very low.
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FIG. 1. The gel filtration pattern of the melanoma extract on a Sephadex G-100 column.
Melanoma extract (118 mg) was applied on the top of the 2.6 x 100 cm column, equilibrated
with 0.01 M phosphate buffer, pH 7.0. Fractions of 5 ml were collected, and the elution
rate was about 15 ml/hr at 40C. The absorbances at 280 nm were measured. Four major
peaks were obtained,
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FIG. 2. The gradient elution pattern of TyI on a DEAE Sephadex A-25 column. Fifty-six
milligrams of Tyl in 5 ml of 0.01 M phosphate buffer, pH 7.0, in the mixing chamber
and 100 ml of 0.5 M NaCi in the same buffer in the reservoir. Fractions of 5 ml were
collected, and the elution rate was about 15 ml/hr at 4'C. The absorbances at 280 nm
were measured. Four peaks were obtained.
TABLE 1
INHIBITORY EFFECT OF TYI ON SOLUBLE TYROSINASE
Tyl
(.tg protein) 02(Al/30 min) Inhibition (%)
Soluble tyrosinasea 51.6
+ Fr. I 30 49.3 4.4
+ Fr.II 33 47.0 8.8
+ Fr. III 27 36.9 28.4
+ Fr.IV 50 30.8 41.3
a Soluble tyrosinase: D.U. = 3.7.
TABLE 2
INHIBITORY EFFECT OF TYROSINASE INHIBITORS ON MELANOSOME TYROSINASE
Tyl
(,ug protein) 02(,l/S0 min) Inhibition (%)
Melanosomea 61 .4
+ Fr. I 30 62.8 -1.8
+ Fr. II 33 60.4 1.6
+ Fr. III 55 60.7 1.1
+ Fr. IV 50 59.8 2.6
a Melanosome: D.U. = 3.75.
3. Inhibitory effect of Tyl subfractions on melanosomal tyrosinase. The inhibi-
tory activities on these four fractions were examined manometrically on the mela-
nosome tyrosinase. As shown in Table 2, no inhibitory activity was found in all
four fractions.
4. Inhibitory effect of the Tyl3 on melanosomes, smooth surface membranes,
and soluble tyrosinase. Then the inhibitory effect of the TyI3 was examined on
the particle-bound tyrosinases (melanosomal and smooth-surface-membrane tyro-
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TABLE 3
INIIIBITORY 1EFFECT OF T1Y3 ON TIIE AMELANOSOMIES, SMOOTH SURIFACE
MIEMBRANES, AND SOLUBLE TYlROSINASE
Fr. III
Eiazymaea (lAg protein) Inihiibitioi (%)
MIelaniosome 58 .5 1 .5
Simiooth membrane 58.5 33 .8
Soluble tyrosinase 58.5 93. 8
aEiizyme activity (AE/10 mili). MIelanosome, 66; silooth imembrane, 61; soluble tyrosinase, 65.
TABLE 4
INHIBITORY EFFECT OF HEAT-TREATED TY13 ON SMOOTII SURFACE AMEMBRANE TYROSINASEa
Fr. III
(,ug proteiml) AE/10 mimi. Inihibition (%)
Smiootli iieembrane _ 90
Nonitreated 39.3 70.5 921.7
Heat treated 39.3 88.5 1.7
a TyI3 was lheat treated at 100(C for 10 mill.
sinase) and on soluble tyrosinase. The results obtained are listed on Table 3. Al-
though the protein contents and tyrosinase activities of the three tyrosinase prepa-
rations used in this particular experiment are almost equal, the inhibitory effect
of TyI3 was found to be present on smooth-surface-membrane tyrosinase and on
soluble tyrosinase but not on melanosomal tyrosinase.
5. The effect of heat treatment of TyI3 on smooth-surface-membr-ane tyrosinase.
The protein nature of the active principle was investigated by observing the effects
of heat on the biological activity. The TyI3 suspension in M/10 phosphate buffer,
pH 6.8, was treated at 1000C for 10 min. The experimental result of the heat
treatment on the inhibitory effect is listed in Table 4. The inhibitory effect of TyI3
on smooth-surface membrane tyrosinase was almost completely abolished.
6. Dose response of TyI3 on soluble tyrosinase. The relationship between the
inhibitory effects on soluble tyrosinase and the amount of Tyl, assayed was studied.
As shown in Fig. 3, the more TyIl used, the more effective the inhibition on soluble
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FIG. 3. Dose response curve between the inhibitory effects on soluble tyrosinase and the
amounts of TyI3 assayed. There was a limit in the inhibitory effect.TYROSINASE REGULATORY FACTORS
TABLE 5
INHIBITORY EFFECT OF Tyls ON TYROSINASE ACTIVITY in situ
TyI3 Inhibition (%)
Control 0
0.1 y 'Y-12
1.0Oy -3
10.0-)Y 5
tyrosinase. The inhibitory effect, however, became limited when about 55% inhibi-
tion had occurred.
7. Inhibitory effect of TyI3 on the tyrosinase activity in melanocytes. Inhibitory
effect of TyI3 on melanogenesis in the melanocytes was investigated by adding vari-
ous amounts of TyI3 to the culture medium. As shown in Table 5, there does not
seem to be present any significant inhibitory effect on the melanogenesis in cultured
melanocytes.
DISCUSSION
In mammals, tyrosinase, the enzyme responsible for melanin formation, is be-
lieved to be synthesized in the ribosomes and transferred via the Golgi area, where
tyrosinase is separated into small units, each of which becomes surrounded by a
membranous envelope (smooth surface membrane). Within each envelope, the
tyrosinase molecules become aligned in an ordered pattern, after which melanin
biosynthesis begins, and the particle is known as a melanosome (1). Tyrosinase
activity was present in isolated ribosomes, where tyrosinase is synthesized; also
in rough endoplasmic reticulum and smooth-surface membranes, where tyrosinase
is located before deposition in the melanosome. On the other hand, tracer studies
have indicated that the specific site of melanin formation in the melanocyte is on
the melanosome and that the presence of tyrosinase activity is not necessarily corre-
lated to the formation of melanin in situ. If this is so, there must be present in
the melanocyte some sort of regulatory mechanism to control tyrosinase activity.
Pro-tyrosinase, a precursor form of the enzyme found in body fluids of insects,
is activated (by the activators) to tyrosinase during metamorphosis (13). In frog
skin it was shown that tyrosinase could be activated significantly by trypsin diges-
tion (14). Mammalian tyrosinase, however, has not been known to possess the
pro-tyrosinase stage. The tyrosinase inhibitors are known to be present in the vari-
ous mouse melanomas (3-5). The inhibitor was extracted from various mouse
melanomas as a heat-stable, dialyzable substance. It fully inhibited soluble tyrosi-
nase, but only partially inhibited melanosomal tyrosinase (3), and could be inacti-
vated by ultraviolet light. Tyrosinase isolated from a nonpigmented strain of the
S91 mouse melanoma apparently could not aggregate into melanosomes, because
its protein carrier was genetically altered. Therefore, albino-tyrosinase remained
associated with its inhibitor and could not produce melanin, even though the en-
zyme had a functioning active center.
The tyrosinase inhibitor described above is of interest with respect to the regula-
tory mechanisms of tyrosinase activity in the melanocyte. The naturally occurring
tyrosinase inhibitor was investigated in Harding-Passey mouse melanomas. Tyrosi-
nase inhibitor (TyI) was isolated from the soluble fraction of melanoma homo-
genate. TyI was found to consist of four fractions: TyIl, TyIL, TyI3, and TyI4.
513SEIJI ET AL.
The inhibitory effect of TyI was shown on the soluble tyrosinase isolated from
the postnuclear supernatant by trypsin digestion. As there is a sigma-shaped dose
response curve between the values of percent inhibition and the amount of TyI3,
it may not be so meaningful to compare their biological activities in terms of per-
cent inhibition per mg protein. The high inhibitory effect was shown in TyI3 and
TyI4. The inhibitory effects shown in TyI3 and TyIl were not shown on melano-
some tyrosinase. The smooth-surface membranes were isolated in order to exam-
ine whether the inhibitory effect of TyI is active on the other particle bound tyro-
sinase. The smooth-surface membranes were chosen since the tyrosinase molecule
is known to be a constitutional element of the membranes (15). Tyrosinase activity
of the smooth-surface membranes was partly inhibited by TyI3, as was that of the
soluble tyrosinase. It is assumed, therefore, that the structural situation of tyrosi-
nase molecule in the smooth-surface membranes is not the same as that in the
melanosomes. Dose response of TyI3 was investigated on the soluble tyrosinase.
As shown in Fig. 3, the dose response curve showed that there was a limit in the
inhibitory effect. When TyI3 was heat treated, the inhibitory activity on the
smooth-surface membrane tyrosinase was abolished.
The melanin-synthesizing activity has been determined in a culture of melano-
cytes (10), and it is now possible to investigate the biological effect of any sub-
stances on the melanogenesis in the living melanocytes. Various amounts of TyI3
were added to the culture media, and the inhibitory effect was examined on the
melanogenesis in the melanocytes. The results obtained are listed in Table 5. No
inhibitory effect was shown. TyI3 did not show any inhibitory effect on the cell
proliferation in the dosage used. As described above, melanogenesis is assumed
to occur only on the melanosomes in the melanocyte, and the TyI3 did not possess
any inhibitory effect on melanosomal tyrosinase. Therefore, the results obtained
are thought to be reasonable since it is expected that TyI3 might not affect melano-
genesis in the melanocyte in vivo. Other factors, however, could account for such
negative results: (1) TyI3, the molecular weight of which would be about 10,000,
may not be able to penetrate into the cytoplasm of the melanocyte, (2) TyI3 may
be denatured and lose its biological activity during the incubation at 370C for 24
hr, or (3) TyI3 may not act on the cultural B-16 mouse melanoma melanocyte
because of cell specificities. The preliminary experiment did not show that the in-
hibitory effect of Tyl on the tyrosinase activity is explained by the sulfhydryl group
contained.
Further experimental studies are needed to clarify the nature of Tyl and the
inhibitory mechanism of the TyI on the various tyrosinases.
SUMMARY
The regulatory mechanisms of tyrosinase activity in melanocytes have been
studied. The inhibitory factors of tyrosinase were investigated in the soluble frac-
tion of Harding-Passey mouse melanoma homogenate. The protein fractions ob-
tained after the soluble-tyrosinase profile in chromatography through a Sephadex
G-100 column showed the inhibitory effect on soluble tyrosinase. Further purifica-
tion was carried out by -continuous gradient elution through a DEAE Sephadex
A-25 column. Four protein profiles were obtained. Two fractions of these possessed
the inhibitory effect on soluble tyrosinase. Soluble tyrosinase and tyrosinase in
smooth membranes were inhibited, but that in melanosomes was not. The inhibi-
514TYROSINASE REGULATORY FACTORS 515
tory effect was completely abolished by boiling. In vivo melanin formation does
not seem to be disturbed by these inhibitors in melanocytes in tissue culture.
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